Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial - Lawitz, E; Lalezari, J P; Hassanein, T (Lancet Infect Dis, 2013)
et al.